Anzeige
Mehr »
Login
Mittwoch, 16.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Global Tactical tritt dem Critical Minerals Institute bei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
385 Leser
Artikel bewerten:
(2)

Mary Kay: Future of Cancer Research: Insights From Women in the Field

Finanznachrichten News

Two world-renowned women in cancer research - one goal - find a cure

NORTHAMPTON, MA / ACCESSWIRE / September 25, 2023 / At Baylor Scott & White in Dallas, Texas, Dr. Joyce O'Shaughnessy is a medical oncologist at the forefront of innovative cancer research focusing on advanced treatment options for metastatic triple-negative breast cancer. Meanwhile, thousands of miles away in Madrid, Spain, Dr. Eva Ciruelos leads clinical trials to better understand breast cancer patients who are unresponsive to certain cancer treatments.

In a personal and inspiring conversation, these two trailblazing women in cancer research discuss the critical topic of female-related cancers, what's on the horizon for their research efforts, and how we can better support women in STEM (science, technology, engineering and mathematics) fields.

Since 1996, the Mary Kay Ash Foundation and Mary Kay Inc. have contributed more than $36 million to cancer research, support programs and services. Across the globe, we are committed to nurturing partnerships aligned with our company's mission of Enriching Women's Lives and we are grateful for pioneering women like Dr. Ciruelos and Dr. O'Shaughnessy who help us remain true to our mission.

Listen to their inspiring conversation on our YouTube channel.

I've chosen to focus on the primary, resistant triple negative breast cancer. That's arguably one of our most difficult, scientific biological questions - why is it that some women's triple negative breast cancer does not respond to the pre-operative therapy? I'm just trying to understand by doing serial biopsies, doing pilot trials of novel therapeutics. Mary Kay has been very supportive of me and others in the U.S. that are working in this area. I really appreciate that because you can't do it without funding. This is strictly philanthropic funding.

Dr. Joyce O'Shaughnessy, Celebrating Women Endowed Chair in Breast Cancer Research at Baylor University Medical Center

Thanks to Mary Kay for this meeting and many other research ideas and initiatives. Thank you all for being here. Stay tuned because breast cancer is improving and clinical research is the key and the answer to many questions we are ready to solve.

Dr. Eva Ciruelos, Breast Cancer Unit Coordinator, University Hospital/HM Hospitals in Madrid and Chair, SOLTI Group on Breast Cancer Research

Dr. Joyce O'Shaughnessy, Celebrating Women Endowed Chair in Breast Cancer Research at Baylor University Medical Center

View additional multimedia and more ESG storytelling from Mary Kay on 3blmedia.com.

Contact Info:
Spokesperson: Mary Kay
Website: https://www.3blmedia.com/profiles/mary-kay
Email: info@3blmedia.com

SOURCE: Mary Kay

View source version on accesswire.com:
https://www.accesswire.com/787233/future-of-cancer-research-insights-from-women-in-the-field

© 2023 ACCESS Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.